ATC/DDD alterations 2021
ATC alterations
| Previous ATC code | ATC level name | New ATC code |
|---|
|
| J05AX08 | raltegravir | J05AJ01
|
| J05AX11 | elvitegravir | J05AJ02
|
| J05AX12 | dolutegravir | J05AJ03
|
| L01XE | Protein kinase inhibitors | deleted
|
| L01XE01 | imatinib | L01EA01
|
| L01XE02 | gefitinib | L01EB01
|
| L01XE03 | erlotinib | L01EB02
|
| L01XE04 | sunitinib | L01EX01
|
| L01XE05 | sorafenib | L01EX02
|
| L01XE06 | dasatinib | L01EA02
|
| L01XE07 | lapatinib | L01EH01
|
| L01XE08 | nilotinib | L01EA03
|
| L01XE09 | temsirolimus | L01EG01
|
| L01XE10 | everolimus | L01EG02
|
| L01XE11 | pazopanib | L01EX03
|
| L01XE12 | vandetanib | L01EX04
|
| L01XE13 | afatinib | L01EB03
|
| L01XE14 | bosutinib | L01EA04
|
| L01XE15 | vemurafenib | L01EC01
|
| L01XE16 | crizotinib | L01ED01
|
| L01XE17 | axitinib | L01EK01
|
| L01XE18 | ruxolitinib | L01EJ01
|
| L01XE19 | ridaforolimus | L01EG03
|
| L01XE21 | regorafenib | L01EX05
|
| L01XE22 | masitinib | L01EX06
|
| L01XE23 | dabrafenib | L01EC02
|
| L01XE24 | ponatinib | L01EA05
|
| L01XE25 | trametinib | L01EE01
|
| L01XE26 | cabozantinib | L01EX07
|
| L01XE27 | ibrutinib | L01EL01
|
| L01XE28 | ceritinib | L01ED02
|
| L01XE29 | lenvatinib | L01EX08
|
| L01XE31 | nintedanib | L01EX09
|
| L01XE32 | cediranib | L01EK02
|
| L01XE33 | palbociclib | L01EF01
|
| L01XE34 | tivozanib | L01EK03
|
| L01XE35 | osimertinib | L01EB04
|
| L01XE36 | alectinib | L01ED03
|
| L01XE37 | rociletinib | L01EB05
|
| L01XE38 | cobimetinib | L01EE02
|
| L01XE39 | midostaurin | L01EX10
|
| L01XE40 | olmutinib | L01EB06
|
| L01XE41 | binimetinib | L01EE03
|
| L01XE42 | ribociclib | L01EF02
|
| L01XE43 | brigatinib | L01ED04
|
| L01XE44 | lorlatinib | L01ED05
|
| L01XE45 | neratinib | L01EH02
|
| L01XE46 | encorafenib | L01EC03
|
| L01XE47 | dacomitinib | L01EB07
|
| L01XE48 | icotinib | L01EB08
|
| L01XE50 | abemaciclib | L01EF03
|
| L01XE51 | acalabrutinib | L01EL02
|
| L01XE52 | quizartinib | L01EX11
|
| L01XE53 | larotrectinib | L01EX12
|
| L01XE54 | gilteritinib | L01EX13
|
| L01XE56 | entrectinib | L01EX14
|
| L01XE57 | fedratinib | L01EJ02
|
| L01XX14 | tretinoin | L01XF01
|
| L01XX17 | topotecan | L01CE01
|
| L01XX19 | irinotecan | L01CE02
|
| L01XX22 | alitretinoin | L01XF02
|
| L01XX25 | bexarotene | L01XF03
|
| L01XX32 | bortezomib | L01XG01
|
| L01XX38 | vorinostat | L01XH01
|
| L01XX39 | romidepsin | L01XH02
|
| L01XX42 | panobinostat | L01XH03
|
| L01XX43 | vismodegib | L01XJ01
|
| L01XX45 | carfilzomib | L01XG02
|
| L01XX46 | olaparib | L01XK01
|
| L01XX47 | idelalisib | L01EM01
|
| L01XX48 | sonidegib | L01XJ02
|
| L01XX49 | belinostat | L01XH04
|
| L01XX50 | ixazomib | L01XG03
|
| L01XX54 | niraparib | L01XK02
|
| L01XX55 | rucaparib | L01XK03
|
| L01XX56 | etirinotecan pegol | L01CE03
|
| L01XX60 | talazoparib | L01XK04
|
| L01XX61 | copanlisib | L01EM02
|
| L01XX63 | glasdegib | L01XJ03
|
| L01XX64 | entinostat | L01XH05
|
| L01XX65 | alpelisib | L01EM03
|
| L01XX68 | belotecan | L01CE04
|
Other ATC alterations
| ATC code | Previous ATC level name | New ATC level name or new ATC level |
|---|
| P01BF04 | artesunate, sulphamethopyrazine and pyrimethamine | artesunate, sulfalene and pyrimethamine |
| C10BA | HMG CoA reductase inhibitors in combination with other lipid modifying agents | Combinations of various lipid modifying agents
|
| C10BX | HMG CoA reductase inhibitors, other combinations | Lipid modifying agents in combination with other drugs
|
| J07BX01 | smallpox, live attenuated | smallpox vaccines
|
DDD alterations
| ATC code | ATC level name | Previous DDD | New DDD |
|---|
| No DDD alterations 2021 |
